Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is -100.00% vs 422.39% in Mar 2025
Other Long Term Liabilities
YoY Growth in year ended Mar 2026 is -100.00% vs -84.62% in Mar 2025
Fixed Assets
YoY Growth in year ended Mar 2026 is -2.90% vs 23.50% in Mar 2025
Investments
YoY Growth in year ended Mar 2026 is -23.81% vs 24.55% in Mar 2025
Current Assets
YoY Growth in year ended Mar 2026 is 19.98% vs 11.12% in Mar 2025
Compare Balance Sheet Results of Anuh Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
50.11
34.96
15.15
43.34%
Share Warrants & Outstandings
Total Reserve
302.11
297.69
4.42
1.48%
Shareholder's Funds
352.22
333.01
19.21
5.77%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
58.60
-58.60
-100.00%
Secured Loans
0.00
58.60
-58.60
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-3.86
-4.58
0.72
15.72%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
2.14
0.68
1.46
214.71%
Total Non-Current Liabilities
-1.72
54.70
-56.42
-103.14%
Current Liabilities
Trade Payables
187.66
68.19
119.47
175.20%
Other Current Liabilities
15.08
6.98
8.10
116.05%
Short Term Borrowings
0.00
29.78
-29.78
-100.00%
Short Term Provisions
0.27
2.22
-1.95
-87.84%
Total Current Liabilities
203.00
107.17
95.83
89.42%
Total Liabilities
553.51
494.88
58.63
11.85%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
120.79
47.89
72.90
152.22%
Less: Accumulated Depreciation
72.26
28.35
43.91
154.89%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
48.52
19.54
28.98
148.31%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
140.02
-140.02
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
39.58
71.89
-32.31
-44.94%
Long Term Loans & Advances
0.69
57.28
-56.59
-98.80%
Other Non Current Assets
5.30
0.01
5.29
52,900.00%
Total Non-Current Assets
102.19
288.73
-186.54
-64.61%
Current Assets Loans & Advances
Current Investments
44.86
51.96
-7.10
-13.66%
Inventories
147.75
11.52
136.23
1,182.55%
Sundry Debtors
238.63
117.24
121.39
103.54%
Cash and Bank
8.30
10.30
-2.00
-19.42%
Other Current Assets
10.33
0.26
10.07
3,873.08%
Short Term Loans and Advances
1.44
14.85
-13.41
-90.30%
Total Current Assets
451.32
206.14
245.18
118.94%
Net Current Assets (Including Current Investments)
248.31
98.98
149.33
150.87%
Total Current Assets Excluding Current Investments
406.46
154.18
252.28
163.63%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
553.51
494.88
58.63
11.85%
Contingent Liabilities
7.45
0.76
6.69
880.26%
Total Debt
0.00
88.38
-88.38
-100.00%
Book Value per share (adjusted)
35.14
95.25
-60.11
-63.11%
Annual - Borrowings
Borrowings 0.00 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -100.00% vs 422.39% in Mar 2025
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.00 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -100.00% vs -84.62% in Mar 2025
Annual - Fixed Assets
Fixed Assets 48.52 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -2.90% vs 23.50% in Mar 2025
Annual - Investments
Investments 39.58 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -23.81% vs 24.55% in Mar 2025
Annual - Current Assets
Current Assets 451.32 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 19.98% vs 11.12% in Mar 2025
